Alpha 2.0
Login Register
» Articles » PMID: 21317588

Integration of Buprenorphine for Substance-abuse Treatment by HIV Care Providers

Overview
Journal J Acquir Immune Defic Syndr
Specialty Infectious Diseases
Date 2011 Feb 15
PMID 21317588
Citations 4
Authors
Gerald Friedland
David Vlahov
Affiliations
Soon will be listed here.
Citing Articles

The prevalence and patterns of substance use by birth cohort among HIV-positive adults in Florida.

Mannes Z, Bryant V, Burrell 2nd L, Lu H, Ferguson E, Zhou Z Aging Ment Health. 2018; 23(4):515-523.

PMID: 29436844 PMC: 6286223. DOI: 10.1080/13607863.2018.1430740.

Primary Care-Based Models for the Treatment of Opioid Use Disorder: A Scoping Review.

Korthuis P, McCarty D, Weimer M, Bougatsos C, Blazina I, Zakher B Ann Intern Med. 2016; 166(4):268-278.

PMID: 27919103 PMC: 5504692. DOI: 10.7326/M16-2149.

Editorial: HIV and Illicit Drugs of Abuse.

Atluri V Front Microbiol. 2016; 7:221.

PMID: 27014190 PMC: 4785150. DOI: 10.3389/fmicb.2016.00221.

A review of pharmacological interactions between HIV or hepatitis C virus medications and opioid agonist therapy: implications and management for clinical practice.

Bruce R, Moody D, Altice F, Gourevitch M, Friedland G Expert Rev Clin Pharmacol. 2013; 6(3):249-69.

PMID: 23656339 PMC: 4198941. DOI: 10.1586/ecp.13.18.